SKGR,SK Growth Opportunities Corporation | Financials

Financials

SKGR

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

SK Growth Opportunities CorporationSKGR

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

179.97M

Revenue (ttm)

n/a

Net Income (ttm)

3.17M

Shares Out

14.97M

EPS (ttm)

0.21

PE Ratio

57.71

Forward PE

n/a

Dividend

n/a

Ex-Dividend Date

n/a

Volume

196,254

Open

11.62

Previous Close

11.44

Day's Range

11.08 - 12.30

52-Week Range

10.39 - 13.40

Beta

-0.03

Analysts

n/a

Price Target

n/a

Earnings Date

n/a

Description >

SK Growth Opportunities Corporation does not have significant operations.

It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.

The company was incorporated in 2021 and is based in New York, New York.

Latest News >

Advance Auto Parts Completes Sale of Worldpac to Carlyle

Nov 4, 2024

10:59 AM EST, 11/04/2024 (MT Newswires) -- Advance Auto Parts ( AAP ) said Monday it has completed the previously announced $1.5 billion sale of Worldpac, its automotive parts wholesale distribution business, to Carlyle Group ( CG ) . Net proceeds from the sale are expected to be roughly $1.2 billion, the company added. Shares of Advance Auto Parts (...

LoanDepot, Smith Douglas Homes Form Joint Venture to Support Financing for New Home Buyers

Nov 4, 2024

10:56 AM EST, 11/04/2024 (MT Newswires) -- LoanDepot ( LDI ) and Smith Douglas Homes ( SDHC ) said Monday they established a joint venture called Ridgeland Mortgage to support financing for new home buyers. The joint venture will operate in Atlanta, Georgia; Houston, Texas; Birmingham and Huntsville, Alabama; Charlotte and Raleigh, North Carolina; and Chattanooga and Nashville, Tennessee, the...

Myriad Genetics Disputes Inclusion of GeneSight in UnitedHealthcare's Coverage Restriction

Nov 4, 2024

10:56 AM EST, 11/04/2024 (MT Newswires) -- Myriad Genetics ( MYGN ) said Monday that it strongly disagrees with UnitedHealthcare's decision to restrict coverage access to multi-gene panel pharmacogenetic tests, including Myriad's GeneSight test, under the commercial and individual exchange benefit plans. The updated policy, which takes effect on Jan. 1, is based on the rationale that there is insufficient...

Eni Completes $1 Billion Alaska Asset Sale, Fast-Tracks Portfolio Goal: Details

Nov 4, 2024

Eni S.p.A. shares are trading higher on Monday. The company disclosed the successful completion of the sale of 100% of its Nikaitchuq and Oooguruk assets in Alaska to Hilcorp for a total value of $1 billion. The transaction, approved by all relevant authorities, aligns with Eni’s strategy to streamline its upstream portfolio by divesting non-core assets. This sale contributes to Eni’s...